Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2022

Feb 14, 2022

29871_dirs_2022-02-14_21616e23-633e-4159-8a39-144917997b42.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-02-10

Reporting Person: Kometer Kevin (Sr MD Chief Information Office)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-10 Common Stock Class A S 2143 $245.07 Disposed 74564 Direct
2022-02-10 Common Stock Class A S 5057 $244.3483 Disposed 69507 Direct
2022-02-10 Common Stock Class A S 6300 $243.4364 Disposed 63207 Direct

Footnotes

F1: On February 10, 2022, Mr. Kometer sold an aggregate of 2,143 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $244.87 to $245.30. The Company maintains a record of the transaction and copies will be provided upon request.

F2: On February 10, 2022, Mr. Kometer sold an aggregate of 5,057 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $243.85 to $244.805. The Company maintains a record of the transaction and copies will be provided upon request.

F3: On February 10, 2022, Mr. Kometer sold an aggregate of 6,300 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $242.84 to $243.84. The Company maintains a record of the transaction and copies will be provided upon request.